An established body of knowledge and clinical practice has argued in favor of the use of glucocorticoids in various chronic inflammatory and autoimmune diseases. However, the very well-known adverse effects associated with their treatment hampers continuation of therapy with glucocorticoids. Analyses of the molecular mechanisms underlying the actions of glucocorticoids have led to the discovery of several mediators that add complexity and diversity to the puzzling world of these hormones and anti-inflammatory drugs. Such mediators hold great promise as alternative pharmacologic tools to be used as anti-inflammatory drugs with the same properties as glucocorticoids, but avoiding their metabolic side effects. This review summarizes findings about the molecular targets and mediators of glucocorticoid function.
Skip Nav Destination
Close
Article navigation
July 2018
-
Cover Image
Cover Image
The 3D structure of recombinant human deoxyribonuclease I. The N-terminal leucine shown in yellow at the top of the structure was selected for PEGylation of the protein. The amino acids shown in yellow towards the bottom of the protein are those interacting with globular actin, a potent inhibitor of human deoxyribonuclease I; for details, see pages 1439–1452.Close Modal
Research Article|
July 31 2018
Defining the role of glucocorticoids in inflammation
Simona Ronchetti
;
Simona Ronchetti
1Department of Medicine, Section of Pharmacology, University of Perugia, Piazza Severi 1, Perugia 06132, Italy
Search for other works by this author on:
Graziella Migliorati
;
Graziella Migliorati
1Department of Medicine, Section of Pharmacology, University of Perugia, Piazza Severi 1, Perugia 06132, Italy
Search for other works by this author on:
Stefano Bruscoli
;
Stefano Bruscoli
1Department of Medicine, Section of Pharmacology, University of Perugia, Piazza Severi 1, Perugia 06132, Italy
Search for other works by this author on:
Carlo Riccardi
1Department of Medicine, Section of Pharmacology, University of Perugia, Piazza Severi 1, Perugia 06132, Italy
Correspondence: Carlo Riccardi (carlo.riccardi@unipg.it)
Search for other works by this author on:
Clin Sci (Lond) (2018) 132 (14): 1529–1543.
Article history
Received:
March 28 2018
Revision Received:
June 14 2018
Accepted:
July 09 2018
Citation
Simona Ronchetti, Graziella Migliorati, Stefano Bruscoli, Carlo Riccardi; Defining the role of glucocorticoids in inflammation. Clin Sci (Lond) 31 July 2018; 132 (14): 1529–1543. doi: https://doi.org/10.1042/CS20171505
Download citation file:
Close
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Cited By
Related Articles
Predictive value of the decrease in circulating dendritic cell precursors in stable coronary artery disease
Clin Sci (Lond) (January,2009)
Nutritional Pharmacology: Effects of l-Arginine on Host Defences, Response to Trauma and Tumour Growth
Clin Sci (Lond) (February,1994)
Koebner phenomenon leading to the formation of new psoriatic lesions: evidences and mechanisms
Biosci Rep (December,2019)